Annual CAPEX
$17.00 K
-$2.18 M-99.23%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual capital expenditures is currently $17.00 thousand, with the most recent change of -$2.18 million (-99.23%) on 31 December 2023. ZBIO annual CAPEX is now -99.23% below its all-time high of $2.20 million, reached on 31 December 2022.ZBIO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly capital expenditures is not available.ZBIO Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology TTM capital expenditures is not available.ZBIO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -99.2% | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
ZBIO CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -99.2% | at low | ||||
5 y | 5 years | -99.2% | at low | ||||
alltime | all time | -99.2% | at low |
ProShares UltraPro Short Nasdaq Biotechnology CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | - | $35.00 K(+59.1%) | $57.00 K(+159.1%) |
Mar 2024 | - | $22.00 K | $22.00 K |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $17.00 K(-99.2%) | - | - |
Dec 2022 | $2.20 M | - | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual capital expenditures?
- What is the all time high annual CAPEX for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for ProShares UltraPro Short Nasdaq Biotechnology?
- What is the all time high TTM CAPEX for ProShares UltraPro Short Nasdaq Biotechnology?
What is ProShares UltraPro Short Nasdaq Biotechnology annual capital expenditures?
The current annual CAPEX of ZBIO is $17.00 K
What is the all time high annual CAPEX for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual capital expenditures is $2.20 M
What is ProShares UltraPro Short Nasdaq Biotechnology annual CAPEX year-on-year change?
Over the past year, ZBIO annual capital expenditures has changed by -$2.18 M (-99.23%)
What is the all time high quarterly CAPEX for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly capital expenditures is $35.00 K
What is the all time high TTM CAPEX for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high TTM capital expenditures is $57.00 K